ArticleFrontiers in immunology2022

Melanocortin receptor agonist NDP-α-MSH improves cognitive deficits and microgliosis but not amyloidosis in advanced stages of AD progression in 5XFAD and 3xTg mice.

Eleonora Daini et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.